New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles

Immunobiology

Volumn 213, Issue 3-4, 2008, Pages 271-283

  Wilk, Esther ^a   Kalippke, Katy ^a   Buyny, Sabine ^a   Schmidt, Reinhold E ^a   Jacobs, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokines; Innate immunity; NK cells

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD27 ANTIGEN; CD31 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GRANZYME B; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; GENE EXPRESSION PROFILING; HOST RESISTANCE; HUMAN; IMMUNOGENETICS; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; VIRUS IMMUNITY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CYTOKINES; GENE EXPRESSION PROFILING; GENOMICS; HEMATOPOIESIS; INTERLEUKIN-12; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MAP KINASE SIGNALING SYSTEM; MICE; RECEPTORS, CXCR3; STAT3 TRANSCRIPTION FACTOR;

EID: 41649119423     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.10.012     Document Type: Review

References (55)

1. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294 (2004) 15-22
2. Berahovich R.D., Lai N.L., Wei Z., Lanier L.L., and Schall T.J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 177 (2006) 7833-7840
3. Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., and Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 171 (1990) 1509-1526
4. Campbell J.D., Cook G., Robertson S.E., Fraser A., Boyd K.S., Gracie J.A., and Franklin I.M. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15. J. Immunol. 167 (2001) 553-561
5. Carson W.E., Fehniger T.A., and Caligiuri M.A. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur. J. Immunol. 27 (1997) 354-360
6. Chakir H., Camilucci A.A., Filion L.G., and Webb J.R. Differentiation of murine NK cells into distinct subsets based on variable expression of the IL-12R beta 2 subunit. J. Immunol. 165 (2000) 4985-4993
7. Chiesa M.D., Vitale M., Carlomagno S., Ferlazzo G., Moretta L., and Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33 (2003) 1657-1666
8. Cruikshank W.W., Lim K., Theodore A.C., Cook J., Fine G., Weller P.F., and Center D.M. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J. Immunol. 157 (1996) 5240-5248
9. Dalbeth N., Gundle R., Davies R.J., Lee Y.C., McMichael A.J., and Callan M.F. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173 (2004) 6418-6426
10. Deniz G., Akdis M., Aktas E., Blaser K., and Akdis C.A. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur. J. Immunol. 32 (2002) 879-884
11. Duprez V., Ferrer M., and Dautry-Varsat A. High-affinity interleukin 2 receptor alpha and beta chains are internalized and remain associated inside the cells after interleukin 2 endocytosis. J. Biol. Chem. 267 (1992) 18639-18643
12. Fagerholm S.C., Hilden T.J., Nurmi S.M., and Gahmberg C.G. Specific integrin alpha and beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms. J. Cell Biol. 171 (2005) 705-715
13. Fan J., Heller N.M., Gorospe M., Atasoy U., and Stellato C. The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur. Respir. J. 26 (2005) 933-947
14. Faure M., and Long E.O. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168 (2002) 6208-6214
15. Ferlazzo G., and Munz C. NK cell compartments and their activation by dendritic cells. J. Immunol. 172 (2004) 1333-1339
16. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., and Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195 (2002) 343-351
17. Freud A.G., Becknell B., Roychowdhury S., Mao H.C., Ferketich A.K., Nuovo G.L., Hughes T.L., Marburger T.B., Sung J., Baiocchi R.A., Guimond M., and Caligiuri M.A. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22 (2005) 295-304
18. Friberg D., Bryant J., Shannon W., and Whiteside T.L. In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. Clin. Diagn. Lab. Immunol. 1 (1994) 261-268
19. Goodridge J.P., Witt C.S., Christiansen F.T., and Warren H.S. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J. Immunol. 171 (2003) 1768-1774
20. Hanna J., Bechtel P., Zhai Y., Youssef F., McLachlan K., and Mandelboim O. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 173 (2004) 6547-6563
21. Hayakawa Y., and Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176 (2006) 1517-1524
22. Jacobs R., Stoll M., Stratmann G., Leo R., Link H., and Schmidt R.E. CD16- CD56+ natural killer cells after bone marrow transplantation. Blood 79 (1992) 3239-3244
23. dim NK cells. Eur. J. Immunol. 31 (2001) 3121-3126
24. Jacobs R., Weber K., Wendt K., Heiken H., and Schmidt R.E. Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients. J. Clin. Immunol. 24 (2004) 281-286
25. Kikuchi-Maki A., Catina T.L., and Campbell K.S. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J. Immunol. 174 (2005) 3859-3863
26. Koopman L.A., Kopcow H.D., Rybalov B., Boyson J.E., Orange J.S., Schatz F., Masch R., Lockwood C.J., Schachter A.D., Park P.J., and Strominger J.L. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198 (2003) 1201-1212
27. Korten S., Wilk E., Gessner J.E., Meyer D., and Schmidt R.E. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d→H-2b and H-2b→H-2d bone marrow chimeras. J. Immunol. 163 (1999) 5896-5905
28. Korten S., Volkmann L., Saeftel M., Fischer K., Taniguchi M., Fleischer B., and Hoerauf A. Expansion of NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control. J. Immunol. 168 (2002) 5199-5206
29. Lanier L.L., Testi R., Bindl J., and Phillips J.H. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169 (1989) 2233-2238
30. Liang S., Wei H., Sun R., and Tian Z. IFNalpha regulates NK cell cytotoxicity through STAT1 pathway. Cytokine 23 (2003) 190-199
31. Lima M., Teixeira M.A., Queiros M.L., Leite M., Santos A.H., Justica B., and Orfao A. Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol. Dis. 27 (2001) 731-743
32. Mehta D.S., Wurster A.L., and Grusby M.J. Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202 (2004) 84-95
33. Moretta A., Poggi A., Pende D., Tripodi G., Orengo A.M., Pella N., Augugliaro R., Bottino C., Ciccone E., and Moretta L. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J. Exp. Med. 174 (1991) 1393-1398
34. Nagler A., Lanier L.L., Cwirla S., and Phillips J.H. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143 (1989) 3183-3191
35. Nakamura Y., Russell S.M., Mess S.A., Friedmann M., Erdos M., Francois C., Jacques Y., Adelstein S., and Leonard W.J. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 369 (1994) 330-333
36. Park Y.R., Choi S.C., Lee S.T., Kim K.S., Chae S.C., and Chung H.T. The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis. Exp. Mol. Med. 37 (2005) 553-558
37. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., Johnston J., Madden K., Xu W., West J., Schrader S., Burkhead S., Heipel M., Brandt C., Kuijper J.L., Kramer J., Conklin D., Presnell S.R., Berry J., Shiota F., Bort S., Hambly K., Mudri S., Clegg C., Moore M., Grant F.J., Lofton-Day C., Gilbert T., Rayond F., Ching A., Yao L., Smith D., Webster P., Whitmore T., Maurer M., Kaushansky K., Holly R.D., and Foster D. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000) 57-63
38. Perez S.A., Mahaira L.G., Sotiropoulou P.A., Gritzapis A.D., Iliopoulou E.G., Niarchos D.K., Cacoullos N.T., Kavalakis Y.G., Antsaklis A.I., Sotiriadou N.N., Baxevanis C.N., and Papamichail M. Effect of IL-21 on NK cells derived from different umbilical cord blood populations. Int. Immunol. 18 (2006) 49-58
39. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189 (1999) 1093-1100
40. Robbins S.H., Tessmer M.S., Mikayama T., and Brossay L. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173 (2004) 259-266
41. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
42. Sarantos M.R., Raychaudhuri S., Lum A.F., Staunton D.E., and Simon S.I. Leukocyte function-associated antigen 1-mediated adhesion stability is dynamically regulated through affinity and valency during bond formation with intercellular adhesion molecule-1. J. Biol. Chem. 280 (2005) 28290-28298
43. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., and Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 101 (2003) 3730-3740
44. Shresta S., Goda P., Wesselschmidt R., and Ley T.J. Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytes. J. Biol. Chem. 272 (1997) 20236-20244
45. Sivori S., Cantoni C., Parolini S., Marcenaro E., Conte R., Moretta L., and Moretta A. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33 (2003) 3439-3447
46. Tanabe Y., Nishibori T., Su L., Arduini R.M., Baker D.P., and David M. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J. Immunol. 174 (2005) 609-613
47. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., and Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7 (1997) 739-751
48. Vosshenrich C.A., Ranson T., Samson S.I., Corcuff E., Colucci F., Rosmaraki E.E., and Di Santo J.P. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174 (2005) 1213-1221
49. Wang G., Tschoi M., Spolski R., Lou Y., Ozaki K., Feng C., Kim G., Leonard W.J., and Hwu P. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63 (2003) 9016-9022
50. bright NK cells. J. Leukoc. Biol. 80 (2006) 1529-1541
51. Wendt K., Wilk E., Buyny S., Schmidt R.E., and Jacobs R. Interleukin-21 differentially affects human natural killer cell subsets. Immunology 122 (2007) 486-495 10.1111/j.1365-2567.2007.02675.x
52. Wilk E., Korten S., Zielinska-Skowronek M., Schmidt R.E., and Meyer-Olson D. Downregulation of Ly49 D expression and its coexpression with Ly49 G2 and Ly49 A after allogeneic bone marrow transplantation. Immunobiology 205 (2002) 267-281
53. Yamada H., Hirai K., Miyamasu M., Iikura M., Misaki Y., Shoji S., Takaishi T., Kasahara T., Morita Y., and Ito K. Eotaxin is a potent chemotaxin for human basophils. Biochem. Biophys. Res. Commun. 231 (1997) 365-368
54. Young H., and Ghosh A.P. Molecular regulation of cytokine gene expression: interferon-gamma as a model system. Prog. Nucleic Acid Res. Mol. Biol. 56 (1997) 109-127
55. Yu A., and Malek T.R. The proteasome regulates receptor-mediated endocytosis of interleukin-2. J. Biol. Chem. 276 (2001) 381-385